MedTrace Logo

Withings ECG-app Study

NCT05316350 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 685

Last updated 2024-03-20

No results posted yet for this study

Summary

The aim of the study is to evaluate the performance of Withings HWA10 with embedded Withings ECG-app in the automatic detection of atrial fibrillation

Conditions

Interventions

DEVICE

Electrocardiogram recording

ECG recording with investigational device

DEVICE

Electrocardiogram recording

ECG recording with reference device

Sponsors & Collaborators

  • Withings

    lead INDUSTRY

  • Syntactx

    collaborator NETWORK

Principal Investigators

  • Jeffrey Wessler, MD · Heartbeat Health

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-15
Primary Completion
2023-08-15
Completion
2023-08-15
FDA Device
Yes

Countries

  • United States
  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05316350 on ClinicalTrials.gov